Recent Updates
Recently added Catalysts
MDAI Positive Sentiment Score: 60/100

Spectral AI Announces Voting Results from 2025 Annual Meeting of Stockholders DALLAS, TX

Key Takeaway: Spectral AI, Inc. announced the voting results from its 2025 Annual Meeting of Stockholders, where significant shareholder participation was recorded with over 60% of total shares represented. Both proposals presented were approved, including the election of six directors to the Board of Directors for another term. Additionally, the appointment of KPMG LLP as the independent registered public accounting firm was ratified, reinforcing the company's commitment to corporate governance and accountability. Spectral AI continues to focus on AI-driven medical diagnostics aimed at improving wound care outcomes.

Market Sentiment Analysis

POSITIVE FACTORS

  • Approval of both proposals at the Annual Meeting demonstrates shareholder support.
  • Election of six directors to the Board of Directors indicates stability in leadership.
  • Appointment of KPMG LLP as the independent registered public accounting firm shows commitment to governance.

Full Press Release Details

Spectral AI Announces Voting Results from 2025
Annual Meeting of Stockholders
DALLAS, TX - May 29, 2025 - Spectral AI,
Inc. (Nasdaq: MDAI) ("Spectral AI" or the "Company"), an artificial intelligence (AI) company focused on
medical diagnostics for faster and more accurate treatment decisions in wound care, announced results from its 2025 Annual Meeting
of Stockholders held earlier today. A total of 15,551,068 shares representing 60.8% of the Company's total shares outstanding
were represented at the meeting, either in person or by proxy. Both of the proposals set forth by the Company were approved by its
The voting results are detailed below. Six directors
were elected to serve on the Company's Board of Directors until the next Annual Meeting of Stockholders:
stockholders also ratified the appointment of KPMG LLP as the Company's independent registered public accounting firm for the 2025
Spectral AI, Inc. is a Dallas-based predictive
AI company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, with initial applications involving
patients with burns. The Company is working to revolutionize the management of wound care by "Seeing the Unknown " with
its DeepView System. The DeepView System is being developed as a predictive device to offer clinicians an objective and immediate
assessment of a burn wound's healing potential prior to treatment or other medical intervention. With algorithm-driven results and
a goal of exceeding the current standard of care in the future, the DeepView System is expected to provide fast and accurate treatment
insight towards value care by improving patient outcomes and reducing healthcare costs. For more information about the DeepView System,
Forward-Looking Statements
Certain statements made in this release are "forward
looking statements" within the meaning of the "safe harbor" provisions of the United States Private Securities Litigation
Reform Act of 1995, including statements regarding the Company's strategy, plans, objectives, initiatives and financial outlook.
When used in this press release, the words "estimates," "projected," "expects," "anticipates,"
"forecasts," "plans," "intends," "believes," "seeks," "may," "will,"
"should," "future," "propose" and variations of these words or similar expressions (or the negative
versions of such words or expressions) are intended to identify forward-looking statements. These forward-looking statements are not guarantees
of future performance, conditions or results, and involve a number of known and unknown risks, uncertainties, assumptions and other important
factors, many of which are outside Company's control, that could cause actual results or outcomes to differ materially from those
discussed in the forward-looking statements. As such, readers are cautioned not to place undue reliance on any forward-looking statements.
Investors should carefully consider the foregoing
factors, and the other risks and uncertainties described in the "Risk Factors" sections of the Company's filings with
the SEC, including the Registration Statement and the other documents filed by the Company. These filings identify and address other important
risks and uncertainties that could cause actual events and results to differ materially from those contained in the forward-looking statements.
For Media and Investor Relations, please contact:
Atlanta Capital Partners LLC
(866) 692-6847 Toll Free - U.S. & Canada
(404) 281-8556 Mobile and WhatsApp

Frequently Asked Questions

What percentage of shares were represented at the Annual Meeting?

60.8% of the total shares outstanding were represented at the meeting.

Who was elected to the Board of Directors?

Six directors were elected to serve on the Board until the next Annual Meeting.

What is the focus of Spectral AI?

Spectral AI specializes in medical diagnostics using AI for wound care improvements.

What is the DeepView System?

The DeepView System assesses burn wound healing potential using predictive algorithms.

Who are the independent auditors for Spectral AI?

KPMG LLP was ratified as the independent public accounting firm for 2025.

Last updated: May 29, 2025